- Home
- CRMD vs INV Comparison
CRMD vs INV Comparison
Compare CRMD & INV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- INV
- Stock Information
- Founded
- CRMD 2006
- INV 2015
- Country
- CRMD United States
- INV United States
- Employees
- CRMD N/A
- INV N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- INV
- Sector
- CRMD Health Care
- INV
- Exchange
- CRMD Nasdaq
- INV NYSE
- Market Cap
- CRMD 645.0M
- INV 615.9M
- IPO Year
- CRMD 2010
- INV N/A
- Fundamental
- Price
- CRMD $10.13
- INV $9.18
- Analyst Decision
- CRMD Strong Buy
- INV Strong Buy
- Analyst Count
- CRMD 6
- INV 1
- Target Price
- CRMD $15.67
- INV $16.00
- AVG Volume (30 Days)
- CRMD 906.0K
- INV 45.0K
- Earning Date
- CRMD 03-11-2025
- INV 03-04-2025
- Dividend Yield
- CRMD N/A
- INV N/A
- EPS Growth
- CRMD N/A
- INV N/A
- EPS
- CRMD N/A
- INV N/A
- Revenue
- CRMD $12,262,234.00
- INV $988,000.00
- Revenue This Year
- CRMD N/A
- INV $2,784.42
- Revenue Next Year
- CRMD $234.92
- INV $215.34
- P/E Ratio
- CRMD N/A
- INV N/A
- Revenue Growth
- CRMD 41184.20
- INV 4.88
- 52 Week Low
- CRMD $3.03
- INV $8.55
- 52 Week High
- CRMD $13.85
- INV $18.75
- Technical
- Relative Strength Index (RSI)
- CRMD 44.90
- INV N/A
- Support Level
- CRMD $9.79
- INV N/A
- Resistance Level
- CRMD $11.28
- INV N/A
- Average True Range (ATR)
- CRMD 0.51
- INV 0.00
- MACD
- CRMD -0.05
- INV 0.00
- Stochastic Oscillator
- CRMD 23.84
- INV 0.00
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.